Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page
- Check4 days agoChange DetectedA new revision entry, v3.5.4, was added to the study's record history, indicating an updated version of the record and replacing the previous v3.5.3 in the history timeline.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA site interface revision marker was updated from version v3.5.2 to v3.5.3, reflecting a non-content update to the page’s release/build labeling.SummaryDifference0.1%

- Check33 days agoChange DetectedThe record history now includes a new revision entry (v3.5.2) and removes the older revision (v3.5.0).SummaryDifference0.1%

- Check62 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the history page.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry v3.4.3 (2026-03-11) was added to the Record History, and the previous revision v3.4.2 (2025-12-30) was listed in deletions.SummaryDifference0.5%

- Check98 days agoChange DetectedA new history entry Revision: v3.4.2 was added and Revision: v3.4.1 removed; there are no changes to study data or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.